Partnership Tool for the Operating Grants: Mechanisms in Brain Aging and Dementia (Factors and Mechanisms that Impact Cognitive Health in Aging)

This Partnership Tool is meant to facilitate connections and collaborations between researchers and knowledge users, including people with lived and living experience, in relation to the Operating Grants: Mechanisms in Brain Aging and Dementia (Factors and Mechanisms that Impact Cognitive Health in Aging) funding opportunity.

The information was provided on a voluntary basis and in no way confers any advantages in the evaluation and funding of applications. Users of the tool use it at their own discretion and responsibility.

The table will be updated weekly until the full application deadline (July 12 2023).


Notice

Important: To be included in the Partnership Tool, please complete this short form. Once completed, your information will be added to the table during the next update.

The information is provided in the language in which it was submitted by the respondent.

Contact information Location Stakeholder/
Participant type
Area(s) of interest Additional information
Marc Poulin
poulin@ucalgary.ca
403-220-8372
University of Calgary
Western Canada (Manitoba, Saskatchewan, Alberta, British Columbia, Northwest Territories, and Yukon) Researcher Healthy Brain Aging and Dementia Prevention Collaborations in the areas of sleep, cerebrovascular regulation, exercise, cognitive function in older adults at increased risk of Alzheimer disease and related dementias.
Francesca Di Cara
dicara@dal.ca
7807080162
Dalhousie University
Eastern Canada (Newfoundland and Labrador, Nova Scotia, Prince Edward Island, and New Brunswick) Early career investigator Emerging evidence suggests that individuals with NDs exhibit changes in the way energy is produced and waste products are removed (metabolism) before they exhibit severe symptoms associated with neurodegeneration. Using the fruit fly, a genetically sophisticated model for human biology, our group found that changes in structures called peroxisomes in cells of the intestine lead to neuroinflammation and to the development of NDs. Peroxisomes are important for the metabolism of many molecules from our diet and act in controlling inflammation. We propose to study how peroxisomal metabolism is linked to and influences NDs to define metabolic and inflammatory signatures that will be predictive of an individual’s potential for ND. We search for predictors of disease. We would like to interact with patients and inform them about our research. We would also like to get to know how to obtain required samples if our questions look legittuime to the association, the patients and the scientific review panel.
Carolyn Tinglin
carolyn_tinglin@sfu.ca
604-725-6028
The Youth Alliance dor Intersectional Justice
Central Canada (Quebec, Ontario, and Nunavut)

Early career investigator

Healthcare Professional

Person With Lived/Living Experience (of the disease, or families and care givers and/or care providers)

Neurodivergent young people and adults:
1. Protective practices for cognitive health.
2. Determinants of health for neurodiverse people. Mental and emotional health of caregivers. 3. Cognitive health of caregivers.
4. Cognitive aging among caregivers of neurodiverse people. Links between neurodiversity and cognitive aging.
Neurodiverse people 20+
Natasha Gallant
Natasha.Gallant@uregina.ca
306-585-4219
University of Regina
Western Canada (Manitoba, Saskatchewan, Alberta, British Columbia, Northwest Territories, and Yukon)

Healthcare Professional Practitioner

Policy Maker/Decision Maker

Person With Lived/Living Experience (of the disease, or families and care givers and/or care providers)

Mechanisms underlying resilience or cognitive reserve that maintain cognitive abilities and/or mitigate risk for cognitive impairment.

Mechanisms underlying resistance that maintain brain health in the presence of pathophysiology.

Role of protective and modifiable risk factors in promoting brain health in aging.

Modifiable risk factors that can delay the onset or slow disease progression.

Please contact Dr. Natasha Gallant at Natasha.Gallant@uregina.ca or (306) 585-4219 for more details regarding our proposed project.
Date modified: